Nano drug crosses blood-brain tumor barrier, targets brain-tumor cells and blood vessels
Wednesday, July 17, 2013 - 16:20
in Health & Medicine
The blood-brain barrier protects the brain from poisons but also prevents drugs from reaching brain tumors. A preclinical study shows that an experimental nanotechnology drug called SapC-DOPS crosses the tumor blood-brain barrier, targets brain-tumor cells and retards growth of tumor blood vessels. The findings also show why the agent targets tumor cells and recommend the drug's further development as a novel treatment for glioblastoma.